PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsSmall cell carcinoma
MeSH D018288 - small cell carcinoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D002277:Carcinoma
18 Companies
3 Drugs
$
Success rate
D018288: 
Small cell carcinoma
20 Companies
3 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaTopotecan Topotecan Teva  2009-09-21   
Cisplatin Cisplatin  2000-05-16   
Novast LaboratoriesTopotecan Topotecan  2016-11-30   
Rising PharmaceuticalsTopotecan Topotecan  2012-08-28   
SandozTopotecan Hycamtin  1996-05-28   
Topotecan Topotecan  2011-02-25   
PfizerTopotecan Topotecan Hospira  2010-06-09   
Dr Reddys LaboratoriesTopotecan Topotecan  2011-03-09   
Sun Pharmaceutical IndustriesTopotecan Topotecan  2013-08-29   
HospiraTopotecan Topotecan  2011-02-02   
Accord HealthcareTopotecan Topotecan  2013-06-26   
Cisplatin Cisplatin  2015-08-18   
Smithkline BeechamTopotecan Evotopin  1997-04-15   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
75%
18/24
Phase 2
11%
5/44
Phase 3
33%
3/9
Approved: 2Overall Success rate: 3%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Cisplatin
Pfizer
Topotecan,
Globulin, immune,
Docetaxol,
Pf00299804
Accord Healthcare
Cisplatin
Smithkline Beecham
Topotecan
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use